| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |